Corporate communications pro at Canale Communications, psyched about life sciences & healthcare
San Diego, CA
Joined December 2009
- Tweets1.1K
- Following262
- Followers273
- Likes76
Pam Lord retweeted
Nice audience at the presentation of data on Sustained Intravesical Release Gemcitabine, and very fruitful discussion on the details of upcoming phase III trial @TARISbio #bladderbase #MIBC #IBCN2019 – at Arhus, Denmark
Shaking up the world of clinical trials; bringing trials closer to the patient. This is really cool! @TrialSpark
Thrilled to announce that @23andMe and TrialSpark are collaborating to reimagine clinical trials and achieve a common end-goal: accelerate the pace, quality, and experience of clinical trials. Learn more and submit your proposal today: trialspark.com/rfp
Pam Lord retweeted
We’re #hiring! We’re a team of innovators looking to help treat patients with debilitating bladder disease. Check out our career page for a full list of open positions: tarisbiomedical.com/careers/ #TARISBio #BladdersMatter
Thank you @robnikolewski and @PolestarCars for including "$63K price tag includes 25% tariffs imposed by Trump admin on cars made in China that are sent to U.S." That's huge, crystal clear consumer impact. #ElectricVehicles will win #EVs
Here's a look at the Polestar 2, the sexy electric vehicle that wants to take on the Tesla Model 3 ... and San Diego is one of five cities in North America that plans to have a retail presence: sandiegouniontribune.com/bus… @sdut @Tesla @PolestarCars #ElectricVehicles #EVs #cars
More intel in story update today: Damage from BG00011 setback may be limited to Biogen @fwpharma Michael Flanagan took broader look at IPF pipeline. firstwordpharma.com/node/166…
Biogen halts mid-stage study of BG00011 in idiopathic pulmonary fibrosis over safety concerns firstwordpharma.com/node/166… $BIIB
Pam Lord retweeted
Repare Therapeutics Announces US$82.5 Million Series B Financing. businesswire.com/news/home/2…
A call for true *patient centricity* in clinical trials - Enough with the me-too drugs. New treatments should be worthy of the people who invest their lives... statnews.com/2019/09/04/me-t… via @statnews
Amazing athletes and MT running community. Had a blast!
A BIG thank you to the @runtherut volunteers, sponsors, spectators & athletes for making this race weekend possible. Rest up, we'll see you next year.
#RunTheRut #BigSkyResort
Thanks @Runtherut for the very nice medals for the 11k #runtherut . We didn’t get them a few years ago and this ones a keeper.
Pam Lord retweeted
Vancouver-based Chinook Therapeutics raises US$65-million in Versant-led financing dlvr.it/RBjXCZ @GlobeBusiness
Chinook Therapeutics bags $65M to bring precision medicine to the kidney; great write-up by @amirahalidrus fiercebiotech.com/biotech/ch…
Cigarette health warnings: yes, bladder cancer leads to blood in urine, also removal of bladder = more impactful message! #FDA #smokingkills fda.gov/tobacco-products/lab…
Thanks @ToddGloria for recognizing the great biotech innovation in #SanDiego and meeting the #GBMDay community at @Tocagen
Pam Lord retweeted
At 24 years of age, Greg Labancz, a patient with #GBM was told he had 2 years to live. He’s been alive for 6 years now. #GBMDay #braincancer #HonorAndAct
Pam Lord retweeted
Assemblymember @ToddGloria joins us today in honor of #GBMDay. He says, “Those of us in Sacramento understand the value of innovation and need to invest in research. Like you, I believe no one should die of cancer.” #HonorAndAct #glioblastoma
Great article by @rleuty_biotech about super cool research, understanding fundamental mechanisms of aging to treat disease @UnityBiotech $UBX
How this CEO plans to turn back the clock on cellular aging bizjournals.com/sanfrancisco… via @SFBusinessTimes
Revisiting Fosfomycin, a “Forgotten” Antibiotic, when our arsenal of effective antibiotics is shrinking | NIH: National Institute of Allergy and Infectious Diseases study info niaid.nih.gov/news-events/re… @Nabriva #AMR
I preach this! 😉 @BrittanyMeiling
